about
Gastric cancer: epidemiologic aspects.Genetic susceptibility and gastric cancer risk.Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activityEpigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: a nested case-control study in the Spanish EPIC cohort.Human vitamin K-dependent GAS6: gene structure, allelic variation, and association with stroke.SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer.Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes.Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23.Common cholesteryl ester transfer protein gene variation related to high-density lipoprotein cholesterol is not associated with decreased coronary heart disease risk after a 10-year follow-up in a Mediterranean cohort: Modulation by alcohol consumptVitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European prospective investigation into cancer and nutrition.Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations.Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and NutriNo association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition.Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European Prospective Investigation into Cancer-Eurgast cohort.Variants in phospholipid metabolism and upstream regulators and non-small cell lung cancer susceptibility.Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort.Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk.DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study.The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition.Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis.Association of alcohol dehydrogenase polymorphisms and life-style factors with excessive alcohol intake within the Spanish population (EPIC-Spain).Aromatic adducts and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort.Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study.Genetic variation in MUC1, MUC2 and MUC6 genes and evolution of gastric cancer precursor lesions in a long-term follow-up in a high-risk area in Spain.Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition.Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohortAromatic DNA Adducts and Risk of Gastrointestinal Cancers: A Case-Cohort Study within the EPIC-SpainCytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST)A novel polymorphism (6376 G/T) in intron 7 of the human protein C geneTwo novel mutations in exon 5 of the protein C gene in two Spanish families with thrombophilia due to protein C deficiencyAcceptor splice site mutation in the invariant AG of intron 5 of the protein C gene, causing type I protein C deficiencyA Locus on Chromosome 2 Influences Levels of Tissue Factor Pathway InhibitorHelicobacter pylori vacA Intermediate Region Genotyping and Progression of Gastric Preneoplastic LesionsExpression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaquesHelicobacter pylori cagA and vacA Genotypes as Predictors of Progression of Gastric Preneoplastic Lesions: A Long-Term Follow-Up in a High-Risk Area in Spain
P50
Q34369146-CA4BE1AB-50A9-4490-AB8A-0E305BC71265Q34736616-EF61D521-CC5E-4C1C-9249-6D371723D667Q36675182-33CD6885-542A-4947-9BD2-E9888902C578Q36903351-8CC19180-3930-4363-BB4C-FA5A7F0E0B3FQ37451300-E6C14AC7-3D2C-456C-B90C-1EF375ED6859Q38820714-0F718D40-ED0C-4344-BF5F-AB29D0ECEA11Q39850072-CA746A08-032F-4A45-8440-C12A64D6A249Q40514979-445AFC60-C424-4CC1-AEE8-B9A95759660BQ40733908-4CC38240-5B00-49B9-AA5D-9B6443ECEDA4Q40813284-24C018BB-3A0B-4CF5-8B5E-EAF554BD1F06Q41006854-4E6AC1F2-2ED8-40EA-B733-9686CA8A0F69Q41580103-2DBBD1C2-B9BF-4EC6-AFD3-D248F01C7957Q43095955-6FE9F88D-D1A8-4C90-9BA8-CF7A010F2C1AQ43199957-F1F1E98E-40B3-483C-9F78-A27A7D06FF32Q43286228-81106E08-DB9B-4F17-8234-3DCA68C5FF92Q43565569-7560F387-FBBA-4D19-BFBD-DFF26B31E9E8Q43885695-33BAEEFB-414E-43FB-A728-66055FED06C6Q43895603-4ABF1BFD-052E-4CD2-8AC9-BDE073E1F5FFQ44672526-843BA94F-0726-4BB3-ABE4-E833EBB6A2FAQ46027256-DD2DF705-3C94-4E21-9EBF-FD4462CE4A0BQ46078250-266B065C-60A4-48EA-9E5E-76A374A6706AQ46104145-5D692062-D4BB-4E40-976D-FF0D372FD929Q46473081-364A9D3E-6409-4C12-A037-AE58ADD68966Q46897482-BD97261A-33C5-4A48-AE89-5DE7342A515DQ49865305-983E1584-2280-4476-9CE4-760A4C5C5CEBQ52300996-745B2F22-6CCC-4BB9-AB27-31049CE05007Q53049434-B833C5B5-EBE2-44F9-B478-653953BE9278Q53061705-9A96224E-188F-4BFA-952F-62055924502DQ53273077-C7957410-B33B-4ABA-9573-A982D9B0A0D6Q53338997-26255DF9-8EDB-4B48-A08E-08129200FB0EQ57037433-F33A5F03-AB00-4B7B-8C8A-A4F9FA64E885Q57252068-523DE298-2D7F-4B5A-A260-D3C8E4289BE9Q57252084-D245B087-153E-46F7-86EA-4496BBC9D233Q57304746-51E816E4-3534-4AB2-8C7C-8E07A60B7C27Q57304758-0B00420B-DD44-461A-952D-38E692775A3CQ57304783-2004C2D9-F160-40ED-9ACC-86C921A412D5Q59590822-062691FD-ECA1-44B9-9F7B-461F1B987067Q60651510-767488FD-017D-4A2D-894C-ED7F006AA5C1Q60651511-393FF623-5606-44C6-B27C-598C27889D84Q60651512-08B2F845-F6DA-4A75-A58A-C68B3724C720
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nuria Sala
@ast
Nuria Sala
@en
Nuria Sala
@es
Nuria Sala
@nl
Nuria Sala
@sl
type
label
Nuria Sala
@ast
Nuria Sala
@en
Nuria Sala
@es
Nuria Sala
@nl
Nuria Sala
@sl
altLabel
Sala N
@en
prefLabel
Nuria Sala
@ast
Nuria Sala
@en
Nuria Sala
@es
Nuria Sala
@nl
Nuria Sala
@sl
P1053
G-8471-2015
P106
P1153
7005539367
P21
P31
P3829
P496
0000-0003-3585-7613
P569
2000-01-01T00:00:00Z